PARKHILL KAREN L 4

4 · Medtronic plc · Filed Aug 2, 2023

Form 4

Period: 2023-07-31

EVP & Chief Financial Officer

Transactions

Award
Ordinary Shares
2023-07-31+12,535→ 44,418 total
Award
Performance Share Units
2023-07-31+31,336→ 31,336 total
→ Performance Share Unit (31,336 underlying)
Award
Stock Option (Right to Buy)
2023-07-31+88,254→ 88,254 total
Exercise: $87.76Exp: 2033-07-31→ Ordinary Shares (88,254 underlying)

Holdings

Footnotes (7)

[F1]Restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.
[F2]Includes 921 units acquired through dividend reinvestment since the last report filed by the reporting person.
[F3]These shares are held in the Jeffrey S. Parkhill 2021 Irrevocable Trust, of which the insider is the trustee and a beneficiary.
[F4]Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
[F5]The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 31,336 shares will be issued. If maximum performance metrics are achieved, 62,672 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
[F6]Vests on July 31, 2026.
[F7]These options become exercisable at the rate of 25% of the shares granted beginning on the first anniversary of the grant.

Documents

1 file